Thoughts and information about the latest news in the world of migraine, cluster headache and other headache treatment around the world.
Posts tagged as:
Yesterday two new studies were released on the Cox-2 class of drugs. Both studies involved Cox-2 drugs taken in combination with other treatments. They found in both cases that there were cardiovascular problems, including a worsening of hardening of the arteries (in mice) and an increased occurrence of heart attack and stroke (in humans). When [...]
{ 0 comments }
As you may have noticed, there are ads all over the place now promoting alternatives to the Cox-2 inhibitors, such as Vioxx, which have come under fire in the last few months. The traditional NSAIDs, such as Advil, have increasingly concerned consumers because of gastrointestinal problems. This is especially a concern for those with chronic [...]
{ 0 comments }
Yesterday the American FDA issued a health advisory regarding the drugs Cox-2 drugs Bextra and Celebrex, and the NSAID naproxen. Basically, they’re recommending that caution should be exercised with the drugs Bextra and Celebrex. Recent studies seem to indicate that they may increase the risk of heart attack and stroke. There is also concern about [...]
{ 0 comments }
The information is coming in so fast that it’s hard to keep up to date! Many of you read in the last issue of HeadWay about emerging concerns about drugs such as Celebrex and Bextra. Now these drugs are getting more attention, and more studies are being done. You will notice some updates in this [...]
{ 0 comments }
Loading ...
